Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report

BACKGROUND: While Coronavirus disease 2019 (Covid-19) vaccines are highly effective, breakthrough infections are occurring. Booster vaccinations have recently received emergency use authorization (EUA) for certain populations but are restricted to homologous mRNA vaccines. We evaluated homologous an...

Descripción completa

Detalles Bibliográficos
Autores principales: Atmar, Robert L., Lyke, Kirsten E., Deming, Meagan E., Jackson, Lisa A., Branche, Angela R., El Sahly, Hana M., Rostad, Christina A., Martin, Judith M., Johnston, Christine, Rupp, Richard E., Mulligan, Mark J., Brady, Rebecca C., Frenck, Robert W., Bäcker, Martín, Kottkamp, Angelica C., Babu, Tara M., Rajakumar, Kumaravel, Edupuganti, Srilatha, Dobryzynski, David, Posavad, Christine M., Archer, Janet I., Crandon, Sonja, Nayak, Seema U., Szydlo, Daniel, Zemanek, Jillian, Dominguez Islas, Clara P., Brown, Elizabeth R., Suthar, Mehul S., McElrath, M. Juliana, McDermott, Adrian B., O’Connell, Sarah E., Montefiori, David C., Eaton, Amanda, Neuzil, Kathleen M., Stephens, David S., Roberts, Paul C., Beigel, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528081/
https://www.ncbi.nlm.nih.gov/pubmed/34671773
http://dx.doi.org/10.1101/2021.10.10.21264827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528081/
https://www.ncbi.nlm.nih.gov/pubmed/34671773
http://dx.doi.org/10.1101/2021.10.10.21264827

Ejemplares similares